AFP and hepatocellular carcinoma: Semenkova and coworkers proposed that a high dose of exogenous addition of AFP derived from different sources (cord serum and culture medium of AFP-secreting HepG2 cells) can induce dose-dependent apoptosis of human hepatoma HepG2 cells [80].